Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Enhanced automation delivers improved traceability and capacity, while increasing manufacturing efficiency

Charles River Laboratories International, Inc. (NYSE: CRL) has successfully implemented its Endosafe ® Cartridge Technology Automated Manufacturing Suite, a significant advancement in bacterial endotoxin testing cartridge production that expands in-process inspection and digital traceability, strengthens manufacturing controls and increases production capacity.

Reaching full operational capacity in Q3 2026, the automated suite is a major investment in advanced manufacturing technologies, designed to strengthen product quality and support the growing demands of customers worldwide. This technology was designed to streamline and optimize testing by consolidating all the essential components into a single disposable cartridge, to provide real-time, quantitative endotoxin analysis.

"Bringing the automated cartridge manufacturing suite to full operation is an important milestone in our commitment to continuous improvement and operational excellence," said Daniel Fernandes, Senior Site Director, Microbial Solutions, Charles River. "Automation and advanced inspection technologies give us greater visibility into manufacturing performance while strengthening process control and traceability."

Delivering Measurable Operational Improvements
Since its inception, the Endosafe ® Cartridge Technology Automated Manufacturing Suite has delivered measurable improvements across quality, manufacturing efficiency, and operational performance.

Since becoming fully operational in July of 2026, key outcomes include:

  • 2% reduction in scrap rates compared to manual cartridge production, resulting in reduced waste.
  • 13% reduction in invalid cartridge rates, resulting in improved product consistency.
  • 14% greater production capacity across Trillium™ and LAL cartridges, to meet growing customer demand.
  • 87% improvement in labor productivity and manufacturing efficiency, enabling higher throughput with fewer production resources while reducing the risk of human error.

Benefits of Automation
The implementation of automated manufacturing processes has improved precision and clarity, enabling enhanced quality, more efficient resource use, faster innovation, and industry modernization.

"Automation is helping us do more than improve quality. It allows us to optimize how we deploy our talent," said Matt Hewitt, Corporate Vice President, Chief Technology Officer Manufacturing, Charles River. "By reducing the manual effort required to manufacture cartridges, we have been able to redirect skilled employees to higher-value initiatives that contribute to continuous improvement and long-term growth."

  • Advancing Quality Through Automated Inspections: A key feature of the new automated suite is its ability to inspect every cartridge, unlike traditional sampling methods. It performs full inspections across critical quality parameters, including cartridge thickness, reagent fill via imaging, package seal integrity, and digital traceability. This ensures a controlled manufacturing environment and greater confidence in product quality and consistency.
  • Improving Supply Chain Quality: The automation initiative has improved Charles River's manufacturing by switching to automated flat-tray packaging, reducing manual handling and enhancing material consistency. These changes have positively impacted both automated and manual processes by increasing raw material quality.
  • Greater Efficiency and Scalability: The automated suite delivers substantial operational efficiencies. The system enables Charles River to maintain production volumes while reducing the labor resources required to manufacture cartridges. This increased productivity supports long-term scalability and positions the company to meet future demand while maintaining rigorous quality standards.
  • Enhanced Traceability for Continuous Improvement: Each cartridge has a unique ID, enabling traceability throughout its lifecycle. This allows manufacturing teams to review data like inspection images, measurements, and packaging results. Enhanced visibility supports faster investigations, improvements, and optimization. Customer feedback combined with manufacturing data offers insights to refine inspection and manufacturing performance.
  • Commitment to Continuous Innovation: The automated cartridge manufacturing suite reflects Charles River's ongoing commitment to innovation, quality, and customer success. By combining advanced automation, comprehensive inspection capabilities, and enhanced process intelligence, the company is establishing a stronger foundation for future growth and continuous product improvement.

"We view this as more than a manufacturing upgrade," said Hewitt. "It is a platform for continuous learning and innovation that will help us deliver even greater quality, consistency, and value to our customers in the years ahead."

About Charles River Laboratories
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com .

Charles River Investor Contact:
Todd Spencer
Corporate Vice President,
Investor Relations
781.222.6455
todd.spencer@crl.com

Charles River Media Contact:
Amy Cianciaruso
Corporate Senior Vice President,
Chief Communications Officer
781.222.6168
amy.cianciaruso@crl.com

News Provided by Business Wire via QuoteMedia

CRL
The Conversation (0)
Strategic Minerals (AIM:SML)

Redmoor - Continuation of High-Grade Tungsten and Identification of High-Grade Tin Zones

Latest drill results confirm strong WO3, Sn and Cu mineralisation; mineralised continuity within the Redmoor SVS high-grade zones; & validity of historical results

Strategic Minerals plc (AIM: SML; USOTC: SMCDF), an international mineral exploration and production company, is delighted to announce that its wholly owned subsidiary, Cornwall Resources Limited ("CRL"), has received assay results from drillhole CRD036 - the first from Pad 2 within the Redmoor... Keep Reading...
Redmoor - Very High-Grade Sample Results Continue to Exceed Expectations

Redmoor - Very High-Grade Sample Results Continue to Exceed Expectations

Second drillhole results reinforce Redmoor's exceptional high-grade nature, with very high-grade sample intersections and multiple thick zones of mineralisation

Strategic Minerals plc (AIM: SML; USOTC: SMCDF), an international mineral exploration and production company, is delighted to announce that its wholly owned subsidiary, Cornwall Resources Limited ("CRL"), has received standout drillhole assay results from CRD034b, including very high-grades and... Keep Reading...
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results

ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results

neffy ® (epinephrine nasal spray) New Drug Application (NDA) and CRL response under review by FDA with anticipated review completion by early October 2024 Response submitted for neffy Marketing Authorization Application (MAA) to EMA's CHMP; CHMP opinion expected in the second quarter of 2024... Keep Reading...
International Graphite (ASX:IG6)

International Graphite Funding Deal with Comet Resources a Win-Win, Report Says

International Graphite’s (ASX:IG6) $1.5-million funding deal with major shareholder Comet Resources (ASX:CRL) resulted in a surge in IG6’s shares on March 13. The loan agreement was undertaken to address market speculation on the security of Comet’s shares in IG6, according to a news report from... Keep Reading...
Comet Resources

Company Update

Comet Resources Limited (Comet or Company) (ASX: CRL) announces that following the discontinuation of the proposed acquisition of the Mount Margaret Copper Project, it is now seeking to raise up to $1.5 million via secured convertible loans to support the Company’s proposed plan to seek... Keep Reading...

Interactive Chart

Latest Press Releases

Related News